Ketorolac Use in Pediatric Patients Undergoing Tonsillectomy

NCT03453541 PHASE4 TERMINATED

This prospective, randomized, double blinded study is designed to compare the bleeding rates of ketorolac vs. placebo when used for post tonsillectomy pain control in pediatric patients ages 2-18.

Details

Lead sponsor	Albany Medical College
Phase	PHASE4
Status	TERMINATED
Enrolment	214
Start date	Tue Nov 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Tue Nov 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Analgesic Adverse Reaction

Interventions

• Ketorolac Tromethamine
• 0.9% Normal Saline

Countries

United States